Target Name: CCDC80
NCBI ID: G151887
Review Report on CCDC80 Target / Biomarker Content of Review Report on CCDC80 Target / Biomarker
CCDC80
Other Name(s): coiled-coil domain containing 80 | Coiled-coil domain containing 80, transcript variant 1 | up-regulated in BRS-3 deficient mouse homolog | Down-regulated by oncogenes protein 1 | okuribin | CCDC80 variant 1 | nuclear envelope protein okuribin | Coiled-coil domain-containing protein 80 | CL2 | LINC01279 | CCDC80 variant 2 | long intergenic non-protein coding RNA 1279 | steroid sensitive gene 1 | Up-regulated in BRS-3 deficient mouse homolog | Coiled-coil domain containing 80, transcript variant 2 | CCD80_HUMAN | Downregulated by oncogenes 1 | TCONS_00006930 | down-regulated by oncogenes protein 1 | SSG1 | URB | DRO1

CDC80: A Protein Involved in Cell Signaling and Cell Adhesion

CCDC80, also known as coiled-coil domain containing 80, is a protein that is expressed in various tissues throughout the body. It is a member of the CCDC family, which is a well-known gene family that is involved in the regulation of cell growth, differentiation, and survival.

CDC80 is a transmembrane protein that is expressed in a variety of tissues, including the brain, heart, liver, and muscle. It is primarily localized to the endoplasmic reticulum, which is the protein synthesis and quality control facility that retrieves and modifies proteins before they are released into the cytoplasm.

One of the unique features of CDC80 is its coiled-coil domain, which is a structural region that is composed of multiple repetitive amino acid sequences that are wrapped together in a specific arrangement. This domain is believed to play a role in the protein's stability and functions as a drug target.

The CCDC80 protein is involved in a variety of cellular processes, including cell signaling, cell adhesion, and cell survival. It is a key regulator of theNotch signaling pathway, which is a well-known regulator of cell growth and differentiation. TheNotch signaling pathway is involved in the regulation of cell fate, and it is thought to play a role in the development and progression of many diseases, including cancer.

In addition to its role in theNotch signaling pathway, CDC80 is also involved in the regulation of cell adhesion. Adhesion is the process by which cells stick together to form tissues and organs, and it is a critical aspect of tissue formation and maintenance. CDC80 is involved in the regulation of cell adhesion by controlling the activity of adhesion molecules, which are proteins that help to hold cells together in tissues.

CDC80 is also involved in the regulation of cell survival. It is a regulator of the cell survival signaling pathway, which is the process by which cells decide when to die and when to continue dividing. This regulation is important for the survival and proliferation of cells , and it is thought to play a role in the development and progression of many diseases.

CDC80 is also a potential drug target in cancer. Many cancer treatments are designed to inhibit the activity of cancer cells, and CDC80 is one of the key proteins that cancer cells use to survive. Researchers are interested in using CDC80 as a target for cancer treatments because they believe that inhibiting its activity may be an effective way to treat cancer.

In conclusion, CDC80 is a protein that is involved in a variety of cellular processes and is a key regulator of theNotch signaling pathway. It is also involved in the regulation of cell adhesion and cell survival, and it is a potential drug target for cancer. Further research is needed to fully understand its role in these processes and to develop effective treatments for cancer.

Protein Name: Coiled-coil Domain Containing 80

Functions: Promotes cell adhesion and matrix assembly

The "CCDC80 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC80 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CCDC81 | CCDC82 | CCDC83 | CCDC85A | CCDC85B | CCDC85C | CCDC86 | CCDC87 | CCDC88A | CCDC88B | CCDC88C | CCDC89 | CCDC9 | CCDC90B | CCDC91 | CCDC92 | CCDC92B | CCDC93 | CCDC96 | CCDC97 | CCDC9B | CCDST | CCEPR | CCER1 | CCER2 | CCHCR1 | CCIN | CCK | CCK receptor | CCKAR | CCKBR | CCL1 | CCL11 | CCL13 | CCL14 | CCL15 | CCL15-CCL14 | CCL16 | CCL17 | CCL18 | CCL19 | CCL2 | CCL20 | CCL21 | CCL22 | CCL23 | CCL24 | CCL25 | CCL26 | CCL27 | CCL28 | CCL3 | CCL3-AS1 | CCL3L1 | CCL3L3 | CCL3P1 | CCL4 | CCL4L1 | CCL4L2 | CCL5 | CCL7 | CCL8 | CCM2 | CCM2L | CCN1 | CCN2 | CCN3 | CCN4 | CCN5 | CCN6 | CCNA1 | CCNA2 | CCNB1 | CCNB1IP1 | CCNB2 | CCNB2P1 | CCNB3 | CCNC | CCND1 | CCND2 | CCND2-AS1 | CCND3 | CCNDBP1 | CCNE1 | CCNE2 | CCNF | CCNG1 | CCNG2 | CCNH | CCNI | CCNI2 | CCNJ | CCNJL | CCNK | CCNL1 | CCNL2 | CCNO | CCNP | CCNQ | CCNQP1